首页 > 最新文献

Nutrition & Metabolism最新文献

英文 中文
Associations of dietary oxidative balance score with sarcopenia in adults: an NHANES-based cross-sectional study.
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-01-22 DOI: 10.1186/s12986-025-00894-4
Qiang Zhou, Shang Zhou, Zuo-Xi Chen, Wu-Jie Zhou, Jia Su, Yong Wang

Background: Sarcopenia, a prevalent muscle disorder in the older adults, is characterized by accelerated loss of muscle mass and function, contributing to increased risks of falls, functional decline, and mortality. The relationship between dietary oxidative balance score (DOBS) and sarcopenia, however, remains unclear.

Methods: We conducted a cross-sectional analysis of the National Health and Nutritional Examination Survey (NHANES) 2011-2018 cohort, which included 8,240 participants, aged 47.2 ± 17.6 years (48.6% male, 51.4% female). The participants were selected from geographic locations across all 50 states and the District of Columbia, using a stratified, multistage probability sampling design to collect health and nutritional data representative of the civilian, non-institutionalized U.S.

Population: We employed the generalized additive model to identify potential non-linear relationships and utilized the two-piecewise linear regression model to investigate the association between DOBS and sarcopenia in American adults.

Results: Participants were categorized into quartiles based on their DOBS, and sarcopenia was diagnosed in 702 individuals (8.5%). In the unadjusted model, DOBS exhibited a significant negative correlation with sarcopenia (β = 0.97, 95% Confidence Interval (CI): 0.96 to 0.99, P < 0.001). This association remained consistent in the model with minimal adjustment for age and gender (β = 0.97, 95% CI: 0.96 to 0.98, P < 0.001) and in the fully adjusted model including additional covariates (β = 0.97, 95% CI: 0.96 to 0.99, P < 0.001). After adjusting for potential confounders, we identified a non-linear association DOBS and sarcopenia, with an inflection point at 23. The effect sizes and CIs to the left and right of the inflection point were 1.62 (95% CI: 1.09 to 2.41, P = 0.016) and 0.97 (95% CI: 0.95 to 0.98, P < 0.001), respectively. Subgroup analyses confirmed the stability of this relationship across various demographic and health-related variables.

Conclusions: This research provides new insights into the association between diet quality, as assessed by DOBS, and sarcopenia, reinforcing the critical role of a balanced, antioxidant-rich diet in adult muscle.

{"title":"Associations of dietary oxidative balance score with sarcopenia in adults: an NHANES-based cross-sectional study.","authors":"Qiang Zhou, Shang Zhou, Zuo-Xi Chen, Wu-Jie Zhou, Jia Su, Yong Wang","doi":"10.1186/s12986-025-00894-4","DOIUrl":"10.1186/s12986-025-00894-4","url":null,"abstract":"<p><strong>Background: </strong>Sarcopenia, a prevalent muscle disorder in the older adults, is characterized by accelerated loss of muscle mass and function, contributing to increased risks of falls, functional decline, and mortality. The relationship between dietary oxidative balance score (DOBS) and sarcopenia, however, remains unclear.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis of the National Health and Nutritional Examination Survey (NHANES) 2011-2018 cohort, which included 8,240 participants, aged 47.2 ± 17.6 years (48.6% male, 51.4% female). The participants were selected from geographic locations across all 50 states and the District of Columbia, using a stratified, multistage probability sampling design to collect health and nutritional data representative of the civilian, non-institutionalized U.S.</p><p><strong>Population: </strong>We employed the generalized additive model to identify potential non-linear relationships and utilized the two-piecewise linear regression model to investigate the association between DOBS and sarcopenia in American adults.</p><p><strong>Results: </strong>Participants were categorized into quartiles based on their DOBS, and sarcopenia was diagnosed in 702 individuals (8.5%). In the unadjusted model, DOBS exhibited a significant negative correlation with sarcopenia (β = 0.97, 95% Confidence Interval (CI): 0.96 to 0.99, P < 0.001). This association remained consistent in the model with minimal adjustment for age and gender (β = 0.97, 95% CI: 0.96 to 0.98, P < 0.001) and in the fully adjusted model including additional covariates (β = 0.97, 95% CI: 0.96 to 0.99, P < 0.001). After adjusting for potential confounders, we identified a non-linear association DOBS and sarcopenia, with an inflection point at 23. The effect sizes and CIs to the left and right of the inflection point were 1.62 (95% CI: 1.09 to 2.41, P = 0.016) and 0.97 (95% CI: 0.95 to 0.98, P < 0.001), respectively. Subgroup analyses confirmed the stability of this relationship across various demographic and health-related variables.</p><p><strong>Conclusions: </strong>This research provides new insights into the association between diet quality, as assessed by DOBS, and sarcopenia, reinforcing the critical role of a balanced, antioxidant-rich diet in adult muscle.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"22 1","pages":"6"},"PeriodicalIF":3.9,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11752774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of metabolic syndrome with different serum vitamin D levels in middle-aged and older adults. 不同血清维生素D水平的中老年人代谢综合征患病率
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-01-20 DOI: 10.1186/s12986-024-00889-7
Ya Zhao, Danting Su, Lichun Huang, Mengjie He, Dan Han, Dong Zhao, Yan Zou, Ronghua Zhang

Background: The relationship between serum vitamin D levels and metabolic syndrome (MetS) has been controversial. This study focused on the relationship between the prevalence of MetS and serum vitamin D levels in middle-aged and elderly people.

Methods: This study included middle-aged and older adults who participated in the 2023 Zhejiang Provincial Nutrition and Health Survey, which was conducted in 90 districts and counties in Zhejiang Province, China.

Results: A total of 11,305 participants were included in this study. MetS was prevalent in 31.7% of participants. Vitamin D and vitamin D3 concentrations were inversely associated with MetS prevalence (Ptrend<0.05), but not with vitamin D2, regardless of whether logistic regression models were adjusted for confounding factors. After adjusting for age, sex, physical activity level, smoking status, education level, annual per capita household income, and body mass index residuals, the highest tertile (Q3) of vitamin D (odds ratio [OR], 0.779; 95% confidence interval [CI], 0.702-0.865) and vitamin D3 (OR, 0.787; 95% CI, 0.709-0.875) concentrations had a lower risk of MetS than the lowest tertile (Q1). We found that vitamin D and D3 levels were correlated with age (Pinteraction<0.05). When age-stratified analyses were performed, vitamin D and vitamin D3 levels were significantly negatively associated with MetS in older adults but not in middle-aged adults.

Conclusions: Low total serum vitamin D and vitamin D3 levels were associated with a higher risk of MetS in adults aged 60 years and older.

背景:血清维生素D水平与代谢综合征(MetS)之间的关系一直存在争议。本研究主要探讨中老年人met患病率与血清维生素D水平之间的关系。方法:本研究纳入了参与2023年浙江省营养与健康调查的中老年人,该调查在浙江省90个区县进行。结果:本研究共纳入11,305名受试者。31.7%的参与者患有met。维生素D和维生素D3浓度与MetS患病率呈负相关(Ptrend2),无论是否根据混杂因素调整逻辑回归模型。在调整了年龄、性别、体力活动水平、吸烟状况、受教育程度、家庭人均年收入和体重指数残差等因素后,维生素D的最高分位数(Q3)为(比值比[OR] 0.779;95%可信区间[CI], 0.702-0.865)和维生素D3 (OR, 0.787;95% CI, 0.709-0.875)浓度的met风险低于最低分位数(Q1)。我们发现维生素D和维生素D3水平与年龄相关。结论:低血清总维生素D和维生素D3水平与60岁及以上成年人met的高风险相关。
{"title":"Prevalence of metabolic syndrome with different serum vitamin D levels in middle-aged and older adults.","authors":"Ya Zhao, Danting Su, Lichun Huang, Mengjie He, Dan Han, Dong Zhao, Yan Zou, Ronghua Zhang","doi":"10.1186/s12986-024-00889-7","DOIUrl":"10.1186/s12986-024-00889-7","url":null,"abstract":"<p><strong>Background: </strong>The relationship between serum vitamin D levels and metabolic syndrome (MetS) has been controversial. This study focused on the relationship between the prevalence of MetS and serum vitamin D levels in middle-aged and elderly people.</p><p><strong>Methods: </strong>This study included middle-aged and older adults who participated in the 2023 Zhejiang Provincial Nutrition and Health Survey, which was conducted in 90 districts and counties in Zhejiang Province, China.</p><p><strong>Results: </strong>A total of 11,305 participants were included in this study. MetS was prevalent in 31.7% of participants. Vitamin D and vitamin D<sub>3</sub> concentrations were inversely associated with MetS prevalence (P<sub>trend</sub><0.05), but not with vitamin D<sub>2</sub>, regardless of whether logistic regression models were adjusted for confounding factors. After adjusting for age, sex, physical activity level, smoking status, education level, annual per capita household income, and body mass index residuals, the highest tertile (Q3) of vitamin D (odds ratio [OR], 0.779; 95% confidence interval [CI], 0.702-0.865) and vitamin D<sub>3</sub> (OR, 0.787; 95% CI, 0.709-0.875) concentrations had a lower risk of MetS than the lowest tertile (Q1). We found that vitamin D and D<sub>3</sub> levels were correlated with age (P<sub>interaction</sub><0.05). When age-stratified analyses were performed, vitamin D and vitamin D3 levels were significantly negatively associated with MetS in older adults but not in middle-aged adults.</p><p><strong>Conclusions: </strong>Low total serum vitamin D and vitamin D<sub>3</sub> levels were associated with a higher risk of MetS in adults aged 60 years and older.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"22 1","pages":"4"},"PeriodicalIF":3.9,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The associations between diet-induced inflammation and the improvement or worsening of hepatic steatosis and fibrosis: a longitudinal analysis of RaNCD cohort study. 饮食引起的炎症与肝脂肪变性和纤维化的改善或恶化之间的关系:一项rand队列研究的纵向分析。
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-01-20 DOI: 10.1186/s12986-025-00897-1
Mohammad Sedighi, Amir Saber, Amir Bagheri, Saba Hazratian, Yahya Pasdar, Farid Najafi, Mehdi Moradinazar, Davood Soleimani

Background: Persistent inflammation plays a crucial role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to scrutinize the associations of diet-induced inflammation with the improvement or worsening of hepatic steatosis and fibrosis in MASLD.

Methods: This longitudinal study involved 2,537 participants from the Ravanser Non-Communicable Disease (RaNCD) cohort (2015-2023). Dietary intake was assessed using the 118-item food frequency questionnaire (FFQ), and diet-induced inflammation was determined using the dietary inflammatory index (DII). The AST to platelet ratio index (APRI) and Fibrosis-4 (FIB-4) were used as confirmed predictive indicators for hepatic fibrosis and the hepatic steatosis index (HSI) was used for hepatic steatosis.

Results: Adherence to an inflammatory diet independently increases the risk of worsening hepatic steatosis (RR:1.39; 95%CI: 1.02-1.93; P-value: 0.04) and reduces the risk of improving hepatic steatosis (RR: 66; 95% CI: 0.48-0.98; P-value: 0.01) compared to an anti-inflammatory diet. The DII scores did not show any connection to hepatic fibrosis, as determined by FIB-4 (β: - 1.08; 95%CI: - 2.43 to 0.27; P-value: 0.12) and APRI (β: 0.22; 95%CI: - 1.51 to 1.95; P-value: 0.80).

Conclusions: These results underscore the importance of dietary composition in managing hepatic steatosis and highlight the need for further research to explore the mechanisms underlying these associations.

背景:持续炎症在代谢功能障碍相关脂肪变性肝病(MASLD)的发病机制中起着至关重要的作用。我们的目的是仔细研究饮食诱导的炎症与MASLD肝脂肪变性和纤维化的改善或恶化之间的关系。方法:这项纵向研究纳入了来自Ravanser非传染性疾病(randd)队列(2015-2023)的2537名参与者。采用包含118个条目的食物频率问卷(FFQ)评估饮食摄入量,并采用饮食炎症指数(DII)确定饮食引起的炎症。以AST /血小板比值指数(APRI)和fibrosis -4 (FIB-4)作为肝纤维化的预测指标,以肝脂肪变性指数(HSI)作为肝脂肪变性的预测指标。结果:坚持炎性饮食会增加肝脂肪变性恶化的风险(RR:1.39;95%置信区间:1.02—-1.93;p值:0.04)并降低肝脂肪变性改善的风险(RR: 66;95% ci: 0.48-0.98;p值:0.01)。根据FIB-4测定,DII评分与肝纤维化没有任何关系(β: - 1.08;95%CI: - 2.43 ~ 0.27;p值:0.12)和APRI (β: 0.22;95%置信区间:- 1.51 ~ 1.95;假定值:0.80)。结论:这些结果强调了饮食组成在控制肝脂肪变性中的重要性,并强调了进一步研究探索这些关联背后机制的必要性。
{"title":"The associations between diet-induced inflammation and the improvement or worsening of hepatic steatosis and fibrosis: a longitudinal analysis of RaNCD cohort study.","authors":"Mohammad Sedighi, Amir Saber, Amir Bagheri, Saba Hazratian, Yahya Pasdar, Farid Najafi, Mehdi Moradinazar, Davood Soleimani","doi":"10.1186/s12986-025-00897-1","DOIUrl":"10.1186/s12986-025-00897-1","url":null,"abstract":"<p><strong>Background: </strong>Persistent inflammation plays a crucial role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to scrutinize the associations of diet-induced inflammation with the improvement or worsening of hepatic steatosis and fibrosis in MASLD.</p><p><strong>Methods: </strong>This longitudinal study involved 2,537 participants from the Ravanser Non-Communicable Disease (RaNCD) cohort (2015-2023). Dietary intake was assessed using the 118-item food frequency questionnaire (FFQ), and diet-induced inflammation was determined using the dietary inflammatory index (DII). The AST to platelet ratio index (APRI) and Fibrosis-4 (FIB-4) were used as confirmed predictive indicators for hepatic fibrosis and the hepatic steatosis index (HSI) was used for hepatic steatosis.</p><p><strong>Results: </strong>Adherence to an inflammatory diet independently increases the risk of worsening hepatic steatosis (RR:1.39; 95%CI: 1.02-1.93; P-value: 0.04) and reduces the risk of improving hepatic steatosis (RR: 66; 95% CI: 0.48-0.98; P-value: 0.01) compared to an anti-inflammatory diet. The DII scores did not show any connection to hepatic fibrosis, as determined by FIB-4 (β: - 1.08; 95%CI: - 2.43 to 0.27; P-value: 0.12) and APRI (β: 0.22; 95%CI: - 1.51 to 1.95; P-value: 0.80).</p><p><strong>Conclusions: </strong>These results underscore the importance of dietary composition in managing hepatic steatosis and highlight the need for further research to explore the mechanisms underlying these associations.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"22 1","pages":"5"},"PeriodicalIF":3.9,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of combined fig-Walnut syrup on functional constipation in pregnant women: a randomized controlled trial. 无花果核桃糖浆对孕妇功能性便秘的影响:一项随机对照试验。
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-01-17 DOI: 10.1186/s12986-025-00895-3
Roghayyeh Valizadeh, Sakineh Mohammad-Alizadeh-Charandabi, Khadijeh Hajizadeh, Mostafa Araj-Khodaei, Mojgan Mirghafourvand

Background: Constipation is one of the most common gastrointestinal complaints during pregnancy. Consuming fruits and vegetables is often the first line of treatment due to their fiber content. Therefore, the purpose of the present study was to determine the effect of combined fig-walnut syrup on functional constipation (FC) and quality of life (QoL) in pregnant women.

Methods: In this double-blind, randomized controlled clinical trial, 90 pregnant women with FC were randomly assigned to receive combined fig-walnut syrup, fig syrup, or placebo (n = 30 in each group) using block randomization. Participants received 15 ml of syrup once daily at night, half an hour before bedtime, for 14 days and were followed up for 2 weeks after the end of the intervention. The FC, quality of life-gravidity (QOL-GRAV), and food frequency questionnaires (FFQ) were used to collect data. The questionnaires were completed once before the intervention and then the FC questionnaire was completed once a week for four weeks and the QoL questionnaire was completed at the end of the fourth week. To compare the outcomes among the study groups, one-way AONOVA, ANCOVA, Mann- Whitney U test, and Kruskal- Wallis test were used.

Results: Following the intervention, although there was no statistically significant difference in the number of defecations between the combined fig-walnut syrup group and the fig syrup group (P > 0.05) at every four weeks, there was a statistically significant difference compared to the placebo (P < 0.05). Combined fig-walnut syrup (adjusted mean difference (AMD): -3.4; 95% confidence interval: -0.7 to -6.1; P = 0.008) and fig syrup (AMD: -5.8; 95% CI: -3.1 to -8.6; P < 0.001) improved QoL compared to the placebo group and there was no statistically significant difference between the combined fig-walnut and fig syrup (AMD: 2.4; 95% CI: 5.2 to -0.3; P = 0.104).

Conclusion: The consumption of fig-walnut syrup and fig syrup may help improve constipation symptoms and enhance QoL during pregnancy. Further studies are needed to reach a conclusive determination.

Trial registration: Iranian Registry of Clinical Trials (IRCT): IRCT2012071801032N79. Date of registration: 07.12.2023.

背景:便秘是妊娠期最常见的胃肠道疾病之一。食用水果和蔬菜通常是治疗的第一线,因为它们富含纤维。因此,本研究的目的是确定无花果核桃糖浆对孕妇功能性便秘(FC)和生活质量(QoL)的影响。方法:在这项双盲、随机对照的临床试验中,采用分组随机法,90名FC孕妇随机分配接受无花果核桃糖浆、无花果糖浆或安慰剂(每组n = 30)。参与者每天晚上在睡前半小时服用15毫升糖浆,持续14天,并在干预结束后随访2周。采用FC、生活质量(QOL-GRAV)和食物频率问卷(FFQ)收集数据。干预前完成1次问卷,然后每周完成1次FC问卷,共4周,第4周结束时完成QoL问卷。为了比较各研究组间的结果,采用单向AONOVA、ANCOVA、Mann- Whitney U检验和Kruskal- Wallis检验。结果:干预后,虽然无花果核桃糖浆联合组与无花果糖浆组每4周排便次数差异无统计学意义(P < 0.05),但与安慰剂组相比差异有统计学意义(P < 0.05)。结论:食用无花果核桃糖浆和无花果糖浆有助于改善妊娠期便秘症状,提高妊娠期生活质量。需要进一步的研究才能得出结论性的结论。试验注册:伊朗临床试验注册中心(IRCT): IRCT2012071801032N79。注册日期:2023年12月7日。
{"title":"The effect of combined fig-Walnut syrup on functional constipation in pregnant women: a randomized controlled trial.","authors":"Roghayyeh Valizadeh, Sakineh Mohammad-Alizadeh-Charandabi, Khadijeh Hajizadeh, Mostafa Araj-Khodaei, Mojgan Mirghafourvand","doi":"10.1186/s12986-025-00895-3","DOIUrl":"https://doi.org/10.1186/s12986-025-00895-3","url":null,"abstract":"<p><strong>Background: </strong>Constipation is one of the most common gastrointestinal complaints during pregnancy. Consuming fruits and vegetables is often the first line of treatment due to their fiber content. Therefore, the purpose of the present study was to determine the effect of combined fig-walnut syrup on functional constipation (FC) and quality of life (QoL) in pregnant women.</p><p><strong>Methods: </strong>In this double-blind, randomized controlled clinical trial, 90 pregnant women with FC were randomly assigned to receive combined fig-walnut syrup, fig syrup, or placebo (n = 30 in each group) using block randomization. Participants received 15 ml of syrup once daily at night, half an hour before bedtime, for 14 days and were followed up for 2 weeks after the end of the intervention. The FC, quality of life-gravidity (QOL-GRAV), and food frequency questionnaires (FFQ) were used to collect data. The questionnaires were completed once before the intervention and then the FC questionnaire was completed once a week for four weeks and the QoL questionnaire was completed at the end of the fourth week. To compare the outcomes among the study groups, one-way AONOVA, ANCOVA, Mann- Whitney U test, and Kruskal- Wallis test were used.</p><p><strong>Results: </strong>Following the intervention, although there was no statistically significant difference in the number of defecations between the combined fig-walnut syrup group and the fig syrup group (P > 0.05) at every four weeks, there was a statistically significant difference compared to the placebo (P < 0.05). Combined fig-walnut syrup (adjusted mean difference (AMD): -3.4; 95% confidence interval: -0.7 to -6.1; P = 0.008) and fig syrup (AMD: -5.8; 95% CI: -3.1 to -8.6; P < 0.001) improved QoL compared to the placebo group and there was no statistically significant difference between the combined fig-walnut and fig syrup (AMD: 2.4; 95% CI: 5.2 to -0.3; P = 0.104).</p><p><strong>Conclusion: </strong>The consumption of fig-walnut syrup and fig syrup may help improve constipation symptoms and enhance QoL during pregnancy. Further studies are needed to reach a conclusive determination.</p><p><strong>Trial registration: </strong>Iranian Registry of Clinical Trials (IRCT): IRCT2012071801032N79. Date of registration: 07.12.2023.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"22 1","pages":"3"},"PeriodicalIF":3.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-sectional and longitudinal associations between serum vitamin D and continuous metabolic syndrome score among children and adolescents: roles of levels of inflammation in peripheral blood. 儿童和青少年血清维生素D与持续代谢综合征评分之间的横断面和纵向关联:外周血炎症水平的作用
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-01-17 DOI: 10.1186/s12986-024-00893-x
Yanyan Li, Zhuang Ma, Yan Li, Ting Xiong, Ziyang Zhang, Bingxuan Kong, Wenlong Lu, Xiu Zhao, Rongfei Zheng, Yuhan Tang, Ping Yao, Zhe Su, Yuanjue Wu, Jingfan Xiong

Background: Serum vitamin D deficiency is intricately linked to metabolic disorders, however, evidence on its association with continuous metabolic risk in children and adolescents remains insufficient. This study aims to elucidate the relationship between serum vitamin D levels and continuous metabolic risk.

Methods: The cross-sectional analysis involved 4490 participants aged 6 ~ 18, and the longitudinal investigation included 1398 individuals aged 6 ~ 12 years. Serum 25(OH)D concentrations were quantified using liquid chromatography-mass spectrometry. Continuous Metabolic syndrome risk score (CMSRS), incorporating waist, blood pressure, blood lipid levels, and glucose metabolism as four components, utilizes age- and gender-specific Z scores to evaluate metabolic risk. Restricted cubic splines (RCS) were used to visualize dose-response relationships and generalized linear models (GLM) were used to estimate potential associations. Mediation analysis was used to evaluate the mediating role of levels of Neutrophil-to-lymphocyte ratio (NLR).

Results: The RCS indicated a negative linear association between serum 25(OH)D levels and CMSRS (P-overall = 0.0066, P-nonlinear = 0.1393). GLM revealed that compared to Q1, with the quartiles of serum 25(OH)D concentrations increase, the β value ranged from 0.028 (95% CI: - 0.093, 0.037) to 0.001(95%CI: - 0.067, 0.069), and then to -0.074 (95%CI: -0.146, -0.003, P for trend = 0.0659). For every 10 ng/mL increase in serum 25(OH)D concentration corresponded to the β value change -0.058 (95%CI: -0.098, -0.017). This association was more pronounced in younger or overweight/obese individuals. Furthermore, in the longitudinal study, as the baseline quartile of serum 25(OH)D concentration increased, the estimated change of subsequent CMSRS indicated a decreasing trend, ranging from -0.085 (95%CI: -0.203, 0.032) to -0.166 (95%CI: - 0.285, - 0.046), and then to - 0.174 (95%CI: - 0.296, -0.053, P for trend = 0.0031). The mediating proportion of levels of NLR was 7.2%.

Conclusions: Higher serum 25(OH)D concentration is significantly associated with reduced CMSRS in children and adolescents, and adequate serum vitamin D levels play a prominent role in preventing long-term metabolic disorders, partly meditating by inflammation in peripheral blood.

背景:血清维生素D缺乏与代谢紊乱有着错综复杂的联系,然而,关于其与儿童和青少年持续代谢风险之间关系的证据仍然不足。本研究旨在阐明血清维生素D水平与持续代谢风险之间的关系。方法:横断面分析纳入6 ~ 18岁4490人,纵向调查纳入6 ~ 12岁1398人。采用液相色谱-质谱法测定血清25(OH)D浓度。持续代谢综合征风险评分(CMSRS)将腰围、血压、血脂水平和葡萄糖代谢作为四个组成部分,利用年龄和性别特异性Z评分来评估代谢风险。限制三次样条(RCS)用于可视化剂量-反应关系,广义线性模型(GLM)用于估计潜在的关联。采用中介分析评价中性粒细胞与淋巴细胞比值(NLR)水平的中介作用。结果:RCS显示血清25(OH)D水平与CMSRS呈负线性相关(P-overall = 0.0066, P-nonlinear = 0.1393)。GLM显示,与Q1相比,随着血清25(OH)D浓度的增加,β值从0.028 (95%CI: - 0.093, 0.037)到0.001(95%CI: - 0.067, 0.069),再到-0.074 (95%CI: -0.146, -0.003, P为趋势= 0.0659)。血清25(OH)D浓度每增加10 ng/mL, β值变化对应于-0.058 (95%CI: -0.098, -0.017)。这种关联在年轻人或超重/肥胖人群中更为明显。此外,在纵向研究中,随着血清25(OH)D浓度基线四分位数的增加,随后CMSRS的估计变化呈下降趋势,范围从-0.085 (95%CI: -0.203, 0.032)到-0.166 (95%CI: - 0.285, - 0.046),再到- 0.174 (95%CI: - 0.296, -0.053, P为趋势= 0.0031)。NLR水平的中介比例为7.2%。结论:较高的血清25(OH)D浓度与儿童和青少年CMSRS降低显著相关,充足的血清维生素D水平在预防长期代谢性疾病中发挥重要作用,部分原因是外周血炎症。
{"title":"Cross-sectional and longitudinal associations between serum vitamin D and continuous metabolic syndrome score among children and adolescents: roles of levels of inflammation in peripheral blood.","authors":"Yanyan Li, Zhuang Ma, Yan Li, Ting Xiong, Ziyang Zhang, Bingxuan Kong, Wenlong Lu, Xiu Zhao, Rongfei Zheng, Yuhan Tang, Ping Yao, Zhe Su, Yuanjue Wu, Jingfan Xiong","doi":"10.1186/s12986-024-00893-x","DOIUrl":"https://doi.org/10.1186/s12986-024-00893-x","url":null,"abstract":"<p><strong>Background: </strong>Serum vitamin D deficiency is intricately linked to metabolic disorders, however, evidence on its association with continuous metabolic risk in children and adolescents remains insufficient. This study aims to elucidate the relationship between serum vitamin D levels and continuous metabolic risk.</p><p><strong>Methods: </strong>The cross-sectional analysis involved 4490 participants aged 6 ~ 18, and the longitudinal investigation included 1398 individuals aged 6 ~ 12 years. Serum 25(OH)D concentrations were quantified using liquid chromatography-mass spectrometry. Continuous Metabolic syndrome risk score (CMSRS), incorporating waist, blood pressure, blood lipid levels, and glucose metabolism as four components, utilizes age- and gender-specific Z scores to evaluate metabolic risk. Restricted cubic splines (RCS) were used to visualize dose-response relationships and generalized linear models (GLM) were used to estimate potential associations. Mediation analysis was used to evaluate the mediating role of levels of Neutrophil-to-lymphocyte ratio (NLR).</p><p><strong>Results: </strong>The RCS indicated a negative linear association between serum 25(OH)D levels and CMSRS (P-overall = 0.0066, P-nonlinear = 0.1393). GLM revealed that compared to Q1, with the quartiles of serum 25(OH)D concentrations increase, the β value ranged from 0.028 (95% CI: - 0.093, 0.037) to 0.001(95%CI: - 0.067, 0.069), and then to -0.074 (95%CI: -0.146, -0.003, P for trend = 0.0659). For every 10 ng/mL increase in serum 25(OH)D concentration corresponded to the β value change -0.058 (95%CI: -0.098, -0.017). This association was more pronounced in younger or overweight/obese individuals. Furthermore, in the longitudinal study, as the baseline quartile of serum 25(OH)D concentration increased, the estimated change of subsequent CMSRS indicated a decreasing trend, ranging from -0.085 (95%CI: -0.203, 0.032) to -0.166 (95%CI: - 0.285, - 0.046), and then to - 0.174 (95%CI: - 0.296, -0.053, P for trend = 0.0031). The mediating proportion of levels of NLR was 7.2%.</p><p><strong>Conclusions: </strong>Higher serum 25(OH)D concentration is significantly associated with reduced CMSRS in children and adolescents, and adequate serum vitamin D levels play a prominent role in preventing long-term metabolic disorders, partly meditating by inflammation in peripheral blood.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"22 1","pages":"2"},"PeriodicalIF":3.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742777/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis. 间歇性禁食对改善代谢性疾病患者肝功能的疗效:一项系统综述和荟萃分析。
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-01-06 DOI: 10.1186/s12986-024-00885-x
Mousa Khalafi, Sara K Rosenkranz, Faeghe Ghasemi, Shokoufeh Kheradmand, Aref Habibi Maleki, Mallikarjuna Korivi, Jung-Piao Tsao
<p><strong>Background: </strong>Intermittent fasting (IF) can be an effective dietary therapy for weight loss and improving cardiometabolic health. However, there is scant evidence regarding the role of IF on indicators of liver function, particularly in adults with metabolic disorders. Therefore, we performed a systematic review and meta-analysis to investigate the effects of IF on liver function in adults with metabolic disorders.</p><p><strong>Methods: </strong>Three primary electronic databases including PubMed, Web of Science, and Scopus, were searched from inception to September 2024 to identify original studies that used IF interventions with or without control groups in adults with metabolic disorders. Inclusion criteria were (1) studies of human participants with metabolic diseases, (2) interventions that evaluated the effects of IF, (3) with or without a control group, and (4) measured liver fat, liver steatosis, liver fibrosis, or liver enzymes, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as primary outcomes. Standardized mean differences (SMD) and 95% confidence intervals were calculated using random effects models. Heterogeneity was assessed using the Cochran's Q statistic and I-squared statistic (I<sup>2</sup>). Publication bias was assessed using the visual inspection of funnel plots and Egger's tests. The risk of bias was assessed using the PEDro scale and the NIH quality assessment tool.</p><p><strong>Results: </strong>A total 21 studies involving 1,226 participants with metabolic disorders were included in the meta-analysis. Overall, IF effectively decreased liver fat with a large effect size [SMD: -1.22 (95% CI: -1.63 to -0.80), p = 0.001], liver steatosis with a medium effect size [SMD: -0.73 (95% CI: -1.12 to -0.35), p = 0.001], ALT with a small effect size [SMD: -0.44 (95% CI: -0.58 to -0.30), p = 0.001], and AST with a small effect size [SMD: -0.30 (95% CI: -0.49 to -0.11), p = 0.001], but not liver fibrosis [SMD: -0.28 (95% CI: -0.59 to 0.02), p = 0.07]. Subgroup analyses showed that IF decreased liver fat and ALT significantly, independent of IF mode, participant age, health status, weight status, and intervention duration. IF significantly decreased liver fibrosis in those with obesity; and decreased AST following 5:2 diets, in middle-aged adults, adults with obesity, and regardless of health status or intervention duration.</p><p><strong>Conclusions: </strong>IF seems to be an effective dietary therapy for improving liver function in adults with metabolic disorders, and many of liver function-related benefits occur regardless of IF mode, intervention duration, or participant health status.</p><p><strong>Limitations: </strong>Significant heterogeneity, small numbers of studies and inclusion of non-randomized trials or single-group pre-post trials were the main limitation of our meta-analysis. Further randomized clinical trials are needed to elucidate the effects of IF on liver function i
背景:间歇性禁食(IF)是一种有效的减肥和改善心脏代谢健康的饮食疗法。然而,关于IF对肝功能指标的作用的证据很少,特别是在患有代谢性疾病的成年人中。因此,我们进行了系统回顾和荟萃分析,以调查IF对代谢性疾病成人肝功能的影响。方法:检索PubMed、Web of Science和Scopus三个主要电子数据库,从成立到2024年9月,以确定在成人代谢紊乱患者中使用或不使用对照组的IF干预的原始研究。纳入标准是:(1)对患有代谢性疾病的人类受试者的研究,(2)评估干扰素影响的干预措施,(3)有或没有对照组,(4)测量肝脏脂肪、肝脂肪变性、肝纤维化或肝酶,包括谷丙转氨酶(ALT)和天冬氨酸转氨酶(AST)作为主要结局。采用随机效应模型计算标准化平均差(SMD)和95%置信区间。采用Cochran's Q统计量和i平方统计量(I2)评估异质性。发表偏倚采用漏斗图的目视检验和Egger检验进行评估。使用PEDro量表和NIH质量评估工具评估偏倚风险。结果:荟萃分析共纳入了21项研究,涉及1226名代谢紊乱患者。总的来说,如果有效降低肝脂肪大效果(SMD: -1.22(95%置信区间CI: -1.63 - -0.80), p = 0.001),肝脏脂肪变性与介质的影响大小(SMD: -0.73(95%置信区间CI: -1.12 - -0.35), p = 0.001), ALT和小尺寸效应(SMD: -0.44(95%置信区间CI: -0.58 - -0.30), p = 0.001),和AST小尺寸效应(SMD: -0.30(95%置信区间CI: -0.49 - -0.11), p = 0.001),但不是肝纤维化(SMD: -0.28(95%置信区间CI: -0.59 - 0.02), p = 0.07)。亚组分析显示,IF可显著降低肝脏脂肪和ALT,与IF模式、参与者年龄、健康状况、体重状况和干预时间无关。IF显著降低肥胖患者肝纤维化;在5:2饮食后,无论健康状况或干预时间长短,中年成年人、肥胖成年人的AST都有所下降。结论:IF似乎是一种有效的饮食疗法,可以改善成人代谢性疾病患者的肝功能,并且与IF模式、干预时间或参与者健康状况无关,许多肝功能相关的益处都会发生。局限性:异质性显著、研究数量少、纳入非随机试验或单组前后试验是本meta分析的主要局限性。需要进一步的随机临床试验来阐明IF对代谢性疾病成人肝功能的影响。
{"title":"Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis.","authors":"Mousa Khalafi, Sara K Rosenkranz, Faeghe Ghasemi, Shokoufeh Kheradmand, Aref Habibi Maleki, Mallikarjuna Korivi, Jung-Piao Tsao","doi":"10.1186/s12986-024-00885-x","DOIUrl":"https://doi.org/10.1186/s12986-024-00885-x","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Intermittent fasting (IF) can be an effective dietary therapy for weight loss and improving cardiometabolic health. However, there is scant evidence regarding the role of IF on indicators of liver function, particularly in adults with metabolic disorders. Therefore, we performed a systematic review and meta-analysis to investigate the effects of IF on liver function in adults with metabolic disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Three primary electronic databases including PubMed, Web of Science, and Scopus, were searched from inception to September 2024 to identify original studies that used IF interventions with or without control groups in adults with metabolic disorders. Inclusion criteria were (1) studies of human participants with metabolic diseases, (2) interventions that evaluated the effects of IF, (3) with or without a control group, and (4) measured liver fat, liver steatosis, liver fibrosis, or liver enzymes, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as primary outcomes. Standardized mean differences (SMD) and 95% confidence intervals were calculated using random effects models. Heterogeneity was assessed using the Cochran's Q statistic and I-squared statistic (I&lt;sup&gt;2&lt;/sup&gt;). Publication bias was assessed using the visual inspection of funnel plots and Egger's tests. The risk of bias was assessed using the PEDro scale and the NIH quality assessment tool.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total 21 studies involving 1,226 participants with metabolic disorders were included in the meta-analysis. Overall, IF effectively decreased liver fat with a large effect size [SMD: -1.22 (95% CI: -1.63 to -0.80), p = 0.001], liver steatosis with a medium effect size [SMD: -0.73 (95% CI: -1.12 to -0.35), p = 0.001], ALT with a small effect size [SMD: -0.44 (95% CI: -0.58 to -0.30), p = 0.001], and AST with a small effect size [SMD: -0.30 (95% CI: -0.49 to -0.11), p = 0.001], but not liver fibrosis [SMD: -0.28 (95% CI: -0.59 to 0.02), p = 0.07]. Subgroup analyses showed that IF decreased liver fat and ALT significantly, independent of IF mode, participant age, health status, weight status, and intervention duration. IF significantly decreased liver fibrosis in those with obesity; and decreased AST following 5:2 diets, in middle-aged adults, adults with obesity, and regardless of health status or intervention duration.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;IF seems to be an effective dietary therapy for improving liver function in adults with metabolic disorders, and many of liver function-related benefits occur regardless of IF mode, intervention duration, or participant health status.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Significant heterogeneity, small numbers of studies and inclusion of non-randomized trials or single-group pre-post trials were the main limitation of our meta-analysis. Further randomized clinical trials are needed to elucidate the effects of IF on liver function i","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"22 1","pages":"1"},"PeriodicalIF":3.9,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142952353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationships between the Planetary Health Diet Index, its food groups, and polygenic risk of obesity in the CARTaGENE cohort. CARTaGENE队列中行星健康饮食指数及其食物组与肥胖多基因风险之间的关系
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-12-31 DOI: 10.1186/s12986-024-00890-0
Guiomar Masip, Daiva E Nielsen

Background: The Planetary Health Diet, proposed by the EAT-Lancet Commission, seeks to promote a sustainable and healthy diet for both humans and the environment. However, few studies have investigated relationships between the Planetary Health Diet and the genetic pathway of obesity. The aim of this study was to assess whether adherence to a Planetary Health Diet Index (PHDI) mediated or moderated the genetic susceptibility to obesity.

Methods: Participants were 7,037 adults (57% females, aged 55.6 ± 7.7) from the Quebec CARTaGENE Biobank. We constructed a primary polygenic risk score (PRS-Khera) for body mass index (BMI) comprised of ~ 2 million SNPs and utilized a secondary 97 SNPs polygenic risk score (PRS-Locke) for sensitivity analyses. The PHDI was based on 16 food groups. General linear models were conducted to assess main effect associations between the PRSs, the Planetary Health Diet Index (PHDI), and the individual food groups that comprise the PHDI on obesity outcomes. Causal mediation analyses (CMA) were used to evaluate mediation and interaction effects. All models were adjusted for age, sex, genetic ancestry, socio-demographic, and lifestyle variables, including those associated with dietary habits.

Results: The overall PHDI was inversely associated with BMI (β = - 0.11, 95% confidence interval (CI): - 0.13, - 0.09), waist circumference (WC) (β = - 0.12, 95% CI: - 0.14, - 0.10), and body fat % (β = - 0.10, 95% CI: - 0.12, - 0.08) for all participants, but did not mediate or moderate obesity polygenic risk. Associations between the PRS-Khera and obesity outcomes in all participants were partly mediated by the intake of red meat (mediation effect BMI: 1.72%, p = 0.01; WC: 2.22%, p = 0.01; body fat %: 2.14%, p = 0.01). Moreover, among males, whole grains intake partly mediated the association between the PRS-Khera and outcomes cross-sectionally (BMI: 1.28%, p = 0.03; WC: 1.71%, p = 0.02; body fat %: 2.19%, p = 0.02) and longitudinally (BMI: 3.80%, p = 0.02; WC: 7.38%, p = 0.04), but some observations were attenuated upon correction for multiple comparisons.

Conclusions: PHDI adherence was associated with a lower BMI, WC, and body fat % and genetic susceptibility to obesity was partly mediated by the intake of red meat and whole grains. Some components of a plant-based diet could be implicated in mechanisms underlying genetic susceptibility to obesity.

背景:全球健康饮食由EAT-Lancet委员会提出,旨在促进人类和环境的可持续健康饮食。然而,很少有研究调查了行星健康饮食与肥胖遗传途径之间的关系。本研究的目的是评估遵守行星健康饮食指数(PHDI)是否介导或减缓了肥胖的遗传易感性。方法:研究对象为来自魁北克CARTaGENE生物库的7037名成年人(57%为女性,年龄55.6±7.7岁)。我们构建了由约200万个snp组成的身体质量指数(BMI)的一级多基因风险评分(PRS-Khera),并利用次级97个snp多基因风险评分(PRS-Locke)进行敏感性分析。PHDI是基于16种食物类别。采用一般线性模型来评估prs、行星健康饮食指数(PHDI)和构成PHDI的单个食物组之间对肥胖结局的主要影响关联。采用因果中介分析(CMA)评价中介效应和交互效应。所有模型都根据年龄、性别、遗传血统、社会人口统计学和生活方式变量(包括与饮食习惯相关的变量)进行了调整。结果:所有参与者的总体PHDI与BMI (β = - 0.11, 95%可信区间(CI): - 0.13, - 0.09)、腰围(WC) (β = - 0.12, 95% CI: - 0.14, - 0.10)和体脂% (β = - 0.10, 95% CI: - 0.12, - 0.08)呈负相关,但不介导或中度肥胖多基因风险。所有参与者的PRS-Khera与肥胖结局之间的关联部分由红肉摄入介导(中介效应BMI: 1.72%, p = 0.01;WC: 2.22%, p = 0.01;体脂%:2.14%,p = 0.01)。此外,在男性中,全谷物摄入在一定程度上介导了PRS-Khera与横断面结局之间的关联(BMI: 1.28%, p = 0.03;WC: 1.71%, p = 0.02;体脂%:2.19%,p = 0.02),纵向(BMI: 3.80%, p = 0.02;WC: 7.38%, p = 0.04),但在多次比较校正后,一些观察值减弱。结论:坚持PHDI与较低的BMI、WC和体脂率有关,而对肥胖的遗传易感性部分是由摄入红肉和全谷物介导的。植物性饮食的某些成分可能与肥胖遗传易感性的潜在机制有关。
{"title":"Relationships between the Planetary Health Diet Index, its food groups, and polygenic risk of obesity in the CARTaGENE cohort.","authors":"Guiomar Masip, Daiva E Nielsen","doi":"10.1186/s12986-024-00890-0","DOIUrl":"10.1186/s12986-024-00890-0","url":null,"abstract":"<p><strong>Background: </strong>The Planetary Health Diet, proposed by the EAT-Lancet Commission, seeks to promote a sustainable and healthy diet for both humans and the environment. However, few studies have investigated relationships between the Planetary Health Diet and the genetic pathway of obesity. The aim of this study was to assess whether adherence to a Planetary Health Diet Index (PHDI) mediated or moderated the genetic susceptibility to obesity.</p><p><strong>Methods: </strong>Participants were 7,037 adults (57% females, aged 55.6 ± 7.7) from the Quebec CARTaGENE Biobank. We constructed a primary polygenic risk score (PRS-Khera) for body mass index (BMI) comprised of ~ 2 million SNPs and utilized a secondary 97 SNPs polygenic risk score (PRS-Locke) for sensitivity analyses. The PHDI was based on 16 food groups. General linear models were conducted to assess main effect associations between the PRSs, the Planetary Health Diet Index (PHDI), and the individual food groups that comprise the PHDI on obesity outcomes. Causal mediation analyses (CMA) were used to evaluate mediation and interaction effects. All models were adjusted for age, sex, genetic ancestry, socio-demographic, and lifestyle variables, including those associated with dietary habits.</p><p><strong>Results: </strong>The overall PHDI was inversely associated with BMI (β = - 0.11, 95% confidence interval (CI): - 0.13, - 0.09), waist circumference (WC) (β = - 0.12, 95% CI: - 0.14, - 0.10), and body fat % (β = - 0.10, 95% CI: - 0.12, - 0.08) for all participants, but did not mediate or moderate obesity polygenic risk. Associations between the PRS-Khera and obesity outcomes in all participants were partly mediated by the intake of red meat (mediation effect BMI: 1.72%, p = 0.01; WC: 2.22%, p = 0.01; body fat %: 2.14%, p = 0.01). Moreover, among males, whole grains intake partly mediated the association between the PRS-Khera and outcomes cross-sectionally (BMI: 1.28%, p = 0.03; WC: 1.71%, p = 0.02; body fat %: 2.19%, p = 0.02) and longitudinally (BMI: 3.80%, p = 0.02; WC: 7.38%, p = 0.04), but some observations were attenuated upon correction for multiple comparisons.</p><p><strong>Conclusions: </strong>PHDI adherence was associated with a lower BMI, WC, and body fat % and genetic susceptibility to obesity was partly mediated by the intake of red meat and whole grains. Some components of a plant-based diet could be implicated in mechanisms underlying genetic susceptibility to obesity.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"21 1","pages":"116"},"PeriodicalIF":3.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11689624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerobic exercise attenuates high-fat diet-induced glycometabolism impairments in skeletal muscle of rat: role of EGR-1/PTP1B signaling pathway. 有氧运动减轻大鼠高脂肪饮食诱导的骨骼肌糖代谢损伤:EGR-1/PTP1B信号通路的作用
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-12-31 DOI: 10.1186/s12986-024-00888-8
Liangzhi Zhang, Xiaojie Liu, Jing Hu, Helong Quan, Sang Ki Lee, Mallikarjuna Korivi, Lifeng Wang, Ting Li, Wei Li

Objective: Impaired skeletal muscle glycogen synthesis contributes to insulin resistance (IR). Aerobic exercise reported to ameliorate IR by augmenting insulin signaling, however the detailed mechanism behind this improvement remains unclear. This study investigated whether aerobic exercise enhances glycogen anabolism and insulin sensitivity via EGR-1/PTP1B signaling pathway in skeletal muscle of rats.

Methods: Sprague-Dawley rats fed a high-fat diet (HFD), and performed treadmill exercise training for 6-week. Oral glucose tolerance test was conducted to confirm the IR. Periodic Acid-Schiff (PAS) staining and anthrone colorimetry were used to assess the skeletal muscle glycogen. RT-qPCR, western blot, and immunofluorescence were used to detect the EGR-1/PTP1B pathway and associated signaling molecules.

Results: We found that exercise training significantly decreased blood glucose, insulin, and homeostasis model assessment for IR (HOMA-IR) against HFD-induced elevation. Decreased muscle glycogen content due to HFD was significantly restored after exercise training. Exercise training promoted mRNA expressions of Irs1, Akt, and Glut4, while inhibited Gsk-3β expression against HFD. Next, the decreased IRS1 (phosphorylated/total), AKT (phosphorylated/total), and GLUT4, and increased GSK-3β proteins with HFD were significantly reversed by exercise. Furthermore, HFD-induced overexpression of EGR-1 and PTP1B evidenced by mRNA, protein, and immunofluorescence intensity, were substantially inhibited by exercise, which may contribute to promote insulin sensitivity and glycogen anabolism.

Conclusions: Aerobic exercise training promotes insulin sensitivity and skeletal muscle glycogen synthesis in HFD-fed rats. The beneficial effects of exercise might be mediated by EGR-1/PTP1B signaling pathway in skeletal muscle, however further studies are necessary to confirm this mechanism.

目的:骨骼肌糖原合成受损与胰岛素抵抗(IR)有关。据报道,有氧运动可以通过增加胰岛素信号来改善IR,但这种改善背后的详细机制尚不清楚。本研究探讨有氧运动是否通过EGR-1/PTP1B信号通路增强大鼠骨骼肌糖原合成代谢和胰岛素敏感性。方法:Sprague-Dawley大鼠饲喂高脂饮食(HFD),并进行6周的跑步机运动训练。口服糖耐量试验证实IR。采用周期性酸-希夫(PAS)染色和蒽酮比色法测定骨骼肌糖原。RT-qPCR、western blot、免疫荧光检测EGR-1/PTP1B通路及相关信号分子。结果:我们发现运动训练可以显著降低血糖、胰岛素和体内稳态模型IR (HOMA-IR)对hfd诱导的升高的影响。运动训练后,HFD引起的肌糖原含量降低得到显著恢复。运动训练促进Irs1、Akt和Glut4 mRNA的表达,抑制Gsk-3β对HFD的表达。接下来,运动显著逆转了IRS1(磷酸化/总)、AKT(磷酸化/总)和GLUT4的降低以及GSK-3β蛋白的升高。此外,运动显著抑制了hfd诱导的EGR-1和PTP1B的过表达(mRNA、蛋白和免疫荧光强度),这可能有助于促进胰岛素敏感性和糖原合成代谢。结论:有氧运动训练促进hfd喂养大鼠胰岛素敏感性和骨骼肌糖原合成。运动的有益作用可能是通过骨骼肌EGR-1/PTP1B信号通路介导的,但这一机制还需要进一步的研究来证实。
{"title":"Aerobic exercise attenuates high-fat diet-induced glycometabolism impairments in skeletal muscle of rat: role of EGR-1/PTP1B signaling pathway.","authors":"Liangzhi Zhang, Xiaojie Liu, Jing Hu, Helong Quan, Sang Ki Lee, Mallikarjuna Korivi, Lifeng Wang, Ting Li, Wei Li","doi":"10.1186/s12986-024-00888-8","DOIUrl":"10.1186/s12986-024-00888-8","url":null,"abstract":"<p><strong>Objective: </strong>Impaired skeletal muscle glycogen synthesis contributes to insulin resistance (IR). Aerobic exercise reported to ameliorate IR by augmenting insulin signaling, however the detailed mechanism behind this improvement remains unclear. This study investigated whether aerobic exercise enhances glycogen anabolism and insulin sensitivity via EGR-1/PTP1B signaling pathway in skeletal muscle of rats.</p><p><strong>Methods: </strong>Sprague-Dawley rats fed a high-fat diet (HFD), and performed treadmill exercise training for 6-week. Oral glucose tolerance test was conducted to confirm the IR. Periodic Acid-Schiff (PAS) staining and anthrone colorimetry were used to assess the skeletal muscle glycogen. RT-qPCR, western blot, and immunofluorescence were used to detect the EGR-1/PTP1B pathway and associated signaling molecules.</p><p><strong>Results: </strong>We found that exercise training significantly decreased blood glucose, insulin, and homeostasis model assessment for IR (HOMA-IR) against HFD-induced elevation. Decreased muscle glycogen content due to HFD was significantly restored after exercise training. Exercise training promoted mRNA expressions of Irs1, Akt, and Glut4, while inhibited Gsk-3β expression against HFD. Next, the decreased IRS1 (phosphorylated/total), AKT (phosphorylated/total), and GLUT4, and increased GSK-3β proteins with HFD were significantly reversed by exercise. Furthermore, HFD-induced overexpression of EGR-1 and PTP1B evidenced by mRNA, protein, and immunofluorescence intensity, were substantially inhibited by exercise, which may contribute to promote insulin sensitivity and glycogen anabolism.</p><p><strong>Conclusions: </strong>Aerobic exercise training promotes insulin sensitivity and skeletal muscle glycogen synthesis in HFD-fed rats. The beneficial effects of exercise might be mediated by EGR-1/PTP1B signaling pathway in skeletal muscle, however further studies are necessary to confirm this mechanism.</p>","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"21 1","pages":"113"},"PeriodicalIF":3.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Impact of fish oil supplementation on plasma levels of highly unsaturated fatty acid-containing lipid classes and molecular species in American football athletes. 更正:补充鱼油对美式橄榄球运动员血浆中含高度不饱和脂肪酸脂类和分子种类水平的影响。
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-12-31 DOI: 10.1186/s12986-024-00878-w
Veronica Anne Mullins, Justin M Snider, Bryce Michael, Lydia Rose Porter, Roberta Diaz Brinton, Floyd H Chilton
{"title":"Correction: Impact of fish oil supplementation on plasma levels of highly unsaturated fatty acid-containing lipid classes and molecular species in American football athletes.","authors":"Veronica Anne Mullins, Justin M Snider, Bryce Michael, Lydia Rose Porter, Roberta Diaz Brinton, Floyd H Chilton","doi":"10.1186/s12986-024-00878-w","DOIUrl":"10.1186/s12986-024-00878-w","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"21 1","pages":"115"},"PeriodicalIF":3.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: The association between age of menopause and type 2 diabetes: a systematic review and meta-analysis. 更正:绝经年龄与 2 型糖尿病之间的关系:系统综述和荟萃分析。
IF 3.9 2区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-12-31 DOI: 10.1186/s12986-024-00891-z
Mansoureh Yazdkhasti, Kyana Jafarabady, Arman Shafiee, Samira Parvizi Omran, Zohre Mahmoodi, Sara Esmaeilzadeh, Touran Bahrami Babaheidari, Kourosh Kabir, Maral Peisepar, Mahmood Bakhtiyari
{"title":"Correction: The association between age of menopause and type 2 diabetes: a systematic review and meta-analysis.","authors":"Mansoureh Yazdkhasti, Kyana Jafarabady, Arman Shafiee, Samira Parvizi Omran, Zohre Mahmoodi, Sara Esmaeilzadeh, Touran Bahrami Babaheidari, Kourosh Kabir, Maral Peisepar, Mahmood Bakhtiyari","doi":"10.1186/s12986-024-00891-z","DOIUrl":"10.1186/s12986-024-00891-z","url":null,"abstract":"","PeriodicalId":19196,"journal":{"name":"Nutrition & Metabolism","volume":"21 1","pages":"114"},"PeriodicalIF":3.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nutrition & Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1